The French drug approval process II: The clinical basis for negative decisions by the commission for authorization of marketing a medication.
Weintraub, M
The French drug approval process II: The clinical basis for negative decisions by the commission for authorization of marketing a medication. [electronic resource] - Journal of clinical pharmacology Apr 1985 - 156-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0091-2700
10.1002/j.1552-4604.1985.tb02819.x doi
Decision Making
Drug Industry--standards
France
Legislation, Drug--trends
Research Design
The French drug approval process II: The clinical basis for negative decisions by the commission for authorization of marketing a medication. [electronic resource] - Journal of clinical pharmacology Apr 1985 - 156-63 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0091-2700
10.1002/j.1552-4604.1985.tb02819.x doi
Decision Making
Drug Industry--standards
France
Legislation, Drug--trends
Research Design